help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fajardo, L. F.
Right arrow Articles by Allison, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fajardo, L. F.
Right arrow Articles by Allison, A. C.

American Journal of Pathology, Vol 140, 539-544, Copyright © 1992 by American Society for Investigative Pathology

REGULAR ARTICLES

Dual role of tumor necrosis factor-alpha in angiogenesis

LF Fajardo, HH Kwan, J Kowalski, SD Prionas and AC Allison
Department of Pathology, Stanford University School of Medicine, California.

The role of tumor necrosis factor-alpha (TNF; cachectin) in angiogenesis has been controversial. In vitro TNF inhibits proliferation of endothelial cells (EC) whereas in the cornea it appears to stimulate vessel growth. The authors tested TNF in their recently developed disc angiogenesis system (DAS), designed to measure the proliferation of microvessels. The DAS, implanted subcutaneously in mice, was either fitted with a central pellet containing mouse recombinant TNF (mrTNF), or exposed to mrTNF delivered subcutaneously by an osmotic minipump. Low doses of mrTNF (0.01-1 ng) induced angiogenesis, which was maximum at 0.1 ng, whereas high doses (1, and 5 micrograms) inhibited it. Subcutaneous mrTNF delivered at the (high) rate of 15-60 ng/hr for 14 days inhibited angiogenesis. These results indicate bimodal, dose-dependent opposing effects and explain some of the in vitro versus in vivo paradoxical results. TNF (native or exogenous) may have opposing effects on microvessels of neoplasms and inflammatory reactions, depending on its local tissue concentrations.


This article has been cited by other articles:


Home page
 J. Am. Soc. Nephrol.Home page
X.-Y. Zhu, E. Daghini, A. R. Chade, C. Napoli, E. L. Ritman, A. Lerman, and L. O. Lerman
Simvastatin Prevents Coronary Microvascular Remodeling in Renovascular Hypertensive Pigs
J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1209 - 1217.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
B. Zhao, G. Smith, J. Cai, A. Ma, and M. Boulton
Vascular endothelial growth factor C promotes survival of retinal vascular endothelial cells via vascular endothelial growth factor receptor-2
Br. J. Ophthalmol., April 1, 2007; 91(4): 538 - 545.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
D. A. Goukassian, G. Qin, C. Dolan, T. Murayama, M. Silver, C. Curry, E. Eaton, C. Luedemann, H. Ma, T. Asahara, et al.
Tumor Necrosis Factor-{alpha} Receptor p75 Is Required in Ischemia-Induced Neovascularization
Circulation, February 13, 2007; 115(6): 752 - 762.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
N. Kociok, S. Radetzky, T. U. Krohne, C. Gavranic, and A. M. Joussen
Pathological but Not Physiological Retinal Neovascularization Is Altered in TNF-Rp55-Receptor-Deficient Mice
Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 5057 - 5065.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
R. van Horssen, T. L. M. ten Hagen, and A. M. M. Eggermont
TNF-{alpha} in Cancer Treatment: Molecular Insights, Antitumor Effects, and Clinical Utility.
Oncologist, April 1, 2006; 11(4): 397 - 408.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
L. S. Barcelos, A. Talvani, A. S. Teixeira, L. Q. Vieira, G. D. Cassali, S. P. Andrade, and M. M. Teixeira
Impaired inflammatory angiogenesis, but not leukocyte influx, in mice lacking TNFR1
J. Leukoc. Biol., August 1, 2005; 78(2): 352 - 358.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
L. Borsi, E. Balza, B. Carnemolla, F. Sassi, P. Castellani, A. Berndt, H. Kosmehl, A. Biro, A. Siri, P. Orecchia, et al.
Selective targeted delivery of TNF{alpha} to tumor blood vessels
Blood, December 15, 2003; 102(13): 4384 - 4392.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Halin, V. Gafner, M. E. Villani, L. Borsi, A. Berndt, H. Kosmehl, L. Zardi, and D. Neri
Synergistic Therapeutic Effects of a Tumor Targeting Antibody Fragment, Fused to Interleukin 12 and to Tumor Necrosis Factor {alpha}
Cancer Res., June 15, 2003; 63(12): 3202 - 3210.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
M. Kinoshita, T. Miyamoto, N. Ohashi, S. Sasayama, and A. Matsumori
Thrombosis Increases Circulatory Hepatocyte Growth Factor by Degranulation of Mast Cells
Circulation, December 10, 2002; 106(24): 3133 - 3138.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Cell Physiol.Home page
B. Gao, T. M. Saba, and M.-F. Tsan
Role of alpha vbeta 3-integrin in TNF-alpha -induced endothelial cell migration
Am J Physiol Cell Physiol, October 1, 2002; 283(4): C1196 - C1205.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
R. MORI, T. KONDO, T. OHSHIMA, Y. ISHIDA, and N. MUKAIDA
Accelerated wound healing in tumor necrosis factor receptor p55-deficient mice with reduced leukocyte infiltration
FASEB J, July 1, 2002; 16(9): 963 - 974.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
A. Jakubowski, B. Browning, M. Lukashev, I. Sizing, J. S. Thompson, C. D. Benjamin, Y.-M. Hsu, C. Ambrose, T. S. Zheng, and L. C. Burkly
Dual role for TWEAK in angiogenic regulation
J. Cell Sci., January 15, 2002; 115(2): 267 - 274.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
F. McLaughlin, V. J. Ludbrook, J. Cox, I. von Carlowitz, S. Brown, and A. M. Randi
Combined genomic and antisense analysis reveals that the transcription factor Erg is implicated in endothelial cell differentiation
Blood, December 1, 2001; 98(12): 3332 - 3339.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Nesbit, H. Schaider, T. H. Miller, and M. Herlyn
Low-Level Monocyte Chemoattractant Protein-1 Stimulation of Monocytes Leads to Tumor Formation in Nontumorigenic Melanoma Cells
J. Immunol., June 1, 2001; 166(11): 6483 - 6490.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Z. Cao, B. C Baguley, and L.-M. Ching
Interferon-inducible Protein 10 Induction and Inhibition of Angiogenesis in Vivo by the Antitumor Agent 5,6-Dimethylxanthenone-4-acetic Acid (DMXAA)
Cancer Res., February 1, 2001; 61(4): 1517 - 1521.
[Abstract] [Full Text]

Home page
 J. Cell Sci.Home page
Y. Han, T. Tuan, H Wu, M Hughes, and W. Garner
TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP
J. Cell Sci., January 1, 2001; 114(1): 131 - 139.
[Abstract] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Iwabe, T. Harada, T. Tsudo, Y. Nagano, S. Yoshida, M. Tanikawa, and N. Terakawa
Tumor Necrosis Factor-{alpha} Promotes Proliferation of Endometriotic Stromal Cells by Inducing Interleukin-8 Gene and Protein Expression
J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 824 - 829.
[Abstract] [Full Text]

Home page
 Mol Hum ReprodHome page
S. Tabibzadeh, P.G. Satyaswaroop, M. von Wolff, and T. Strowitzki
Regulation of TNF-{alpha} mRNA expression in endometrial cells by TNF-{alpha} and by oestrogen withdrawal
Mol. Hum. Reprod., December 1, 1999; 5(12): 1141 - 1149.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
A. Dahlqvist, E. Y. Umemoto, J. J. Brokaw, M. Dupuis, and D. M. McDonald
Tissue Macrophages Associated with Angiogenesis in Chronic Airway Inflammation in Rats
Am. J. Respir. Cell Mol. Biol., February 1, 1999; 20(2): 237 - 247.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. R. Jackson, B. Bolognese, L. Hillegass, S. Kassis, J. Adams, D. E. Griswold, and J. D. Winkler
Pharmacological Effects of SB 220025, a Selective Inhibitor of P38 Mitogen-Activated Protein Kinase, in Angiogenesis and Chronic Inflammatory Disease Models
J. Pharmacol. Exp. Ther., February 1, 1998; 284(2): 687 - 692.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
F. Mackay, G. R. Majeau, P. S. Hochman, and J. L. Browning
Lymphotoxin beta Receptor Triggering Induces Activation of the Nuclear Factor kappa B Transcription Factor in Some Cell Types
J. Biol. Chem., October 4, 1996; 271(40): 24934 - 24938.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
V. Kainulainen, L. Nelimarkka, H. Jarvelainen, M. Laato, M. Jalkanen, and K. Elenius
Suppression of Syndecan-1 Expression in Endothelial Cells by Tumor Necrosis Factor-alpha
J. Biol. Chem., August 2, 1996; 271(31): 18759 - 18766.
[Abstract] [Full Text] [PDF]

Home page
 J Oncol Pharm PractHome page
K. R. Dover and A. W. Valley
Review : Angiogenesis: A new target for antineoplastic therapy
Journal of Oncology Pharmacy Practice, January 1, 1996; 2(1): 43 - 60.
[Abstract] [PDF]

Home page
 ScienceHome page
A Pandey, H Shao, R. Marks, P. Polverini, and V. Dixit
Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis
Science, April 28, 1995; 268(5210): 567 - 569.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
Y.-P. Han, T.-L. Tuan, M. Hughes, H. Wu, and W. L. Garner
Transforming Growth Factor-beta - and Tumor Necrosis Factor-alpha -mediated Induction and Proteolytic Activation of MMP-9 in Human Skin
J. Biol. Chem., June 15, 2001; 276(25): 22341 - 22350.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
J. Yu, S. Tian, L. Metheny-Barlow, L.-J. Chew, A. J. Hayes, H. Pan, G.-L. Yu, and L.-Y. Li
Modulation of Endothelial Cell Growth Arrest and Apoptosis by Vascular Endothelial Growth Inhibitor
Circ. Res., December 7, 2001; 89(12): 1161 - 1167.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the American Society for Investigative Pathology.